May 21, 2026 Sweden
BioStock: Diamyd Medical's facility achieves GMP certification
In an interview with BioStock, Sofia Mayans, Head of Manufacturing, comments on the GMP certification from the Swedish Medical Products Agency. The certification marks an important milestone for Diamyd Medical’s recombinant protein platform and strengthens the company’s position for future manufacturing, partnerships, and expansion opportunities.
Read the article here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.